| Primary |
| Overdose |
22.3% |
| Ill-defined Disorder |
19.1% |
| Ototoxicity |
10.6% |
| Product Used For Unknown Indication |
9.6% |
| Prophylaxis |
5.3% |
| Chronic Obstructive Pulmonary Disease |
4.3% |
| Cough |
3.2% |
| Nasopharyngitis |
3.2% |
| Respiratory Fume Inhalation Disorder |
3.2% |
| Catheterisation Cardiac |
2.1% |
| Drug Toxicity |
2.1% |
| Gastric Ulcer |
2.1% |
| Pulmonary Fibrosis |
2.1% |
| Renal Disorder |
2.1% |
| Therapeutic Agent Toxicity |
2.1% |
| Toxicity To Various Agents |
2.1% |
| Analgesic Drug Level Increased |
1.1% |
| Angioplasty |
1.1% |
| Cardiac Operation |
1.1% |
| Cystic Fibrosis |
1.1% |
|
| Medication Error |
33.8% |
| Hypotension |
7.7% |
| Overdose |
6.2% |
| Drug Ineffective |
4.6% |
| Incorrect Dose Administered |
4.6% |
| Incorrect Route Of Drug Administration |
4.6% |
| Respiratory Arrest |
4.6% |
| Anaphylactic Shock |
3.1% |
| Anaphylactoid Reaction |
3.1% |
| Rash |
3.1% |
| Spina Bifida |
3.1% |
| Status Asthmaticus |
3.1% |
| Tachycardia |
3.1% |
| Throat Tightness |
3.1% |
| Vomiting |
3.1% |
| Wheezing |
3.1% |
| Abdominal Discomfort |
1.5% |
| Adverse Event |
1.5% |
| Agitation |
1.5% |
| Anaphylactic Reaction |
1.5% |
|
| Secondary |
| Hypertension |
13.7% |
| Product Used For Unknown Indication |
13.7% |
| Chronic Obstructive Pulmonary Disease |
10.4% |
| Pain |
8.8% |
| Drug Use For Unknown Indication |
5.3% |
| Psoas Abscess |
5.1% |
| Thrombosis Prophylaxis |
4.5% |
| Prophylaxis |
4.4% |
| Drug Therapy |
3.8% |
| Sedation |
3.6% |
| Supplementation Therapy |
3.3% |
| Cardiac Failure |
3.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.9% |
| Pyrexia |
2.8% |
| Nutritional Support |
2.8% |
| Infection Prophylaxis |
2.6% |
| Cough |
2.5% |
| Restlessness |
2.4% |
| Pneumonia |
2.2% |
| Fluid Replacement |
2.2% |
|
| Toxic Epidermal Necrolysis |
33.5% |
| Stevens-johnson Syndrome |
19.1% |
| Hyponatraemia |
5.2% |
| Unevaluable Event |
5.2% |
| Medication Error |
4.0% |
| Suicide Attempt |
3.5% |
| Thermal Burn |
3.5% |
| Drug Exposure During Pregnancy |
2.9% |
| Drug Ineffective |
2.9% |
| Urticaria |
2.9% |
| Venoocclusive Liver Disease |
2.3% |
| Angiopathy |
1.7% |
| Cerebral Haemorrhage |
1.7% |
| Drug Hypersensitivity |
1.7% |
| Haematoma |
1.7% |
| Joint Swelling |
1.7% |
| Overdose |
1.7% |
| Pruritus |
1.7% |
| Trisomy 21 |
1.7% |
| Cytolytic Hepatitis |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.2% |
| Drug Use For Unknown Indication |
24.2% |
| Prophylaxis |
7.9% |
| Surgery |
7.5% |
| Hypertension |
6.2% |
| Diffuse Large B-cell Lymphoma |
3.5% |
| Medical Diet |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.8% |
| Pain |
2.7% |
| Abdominal Pain |
2.6% |
| Non-small Cell Lung Cancer |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Oesophagitis |
1.9% |
| Cough |
1.3% |
| Constipation |
1.3% |
| Infection |
1.2% |
| Nausea |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
| Bronchitis |
1.1% |
| Hepatic Neoplasm Malignant |
1.1% |
|
| Renal Failure |
8.0% |
| Death |
7.8% |
| Pneumonia |
7.8% |
| Vomiting |
7.6% |
| Pyrexia |
7.5% |
| Weight Decreased |
6.8% |
| Nephropathy Toxic |
6.6% |
| Thrombocytopenia |
5.7% |
| Renal Failure Acute |
5.6% |
| Respiratory Failure |
5.4% |
| Sepsis |
5.2% |
| Abdominal Pain |
4.0% |
| Toxic Epidermal Necrolysis |
3.6% |
| Tachycardia |
3.3% |
| Urinary Tract Infection |
3.1% |
| Rash |
2.6% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Hypotension |
2.4% |
| Dyspnoea |
2.3% |
| Nausea |
2.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Nasopharyngitis |
50.0% |
|
| Suicidal Ideation |
50.0% |
| Rhabdomyolysis |
33.3% |
| Blood Creatinine Increased |
16.7% |
|
